Novo Nordisk stock climbs following the announcement of its plans to advance amycretin, a dual GLP-1/amylin agonist for ...

Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. Novo Nordisk's ADR (NVO) (DK:NOVO.B), at ...

Positive news from the laboratory was the wind beneath the wings of Novo Nordisk (NYSE: NVO) stock on Thursday. The ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

The stock market is a place where people tend to panic when things go on sale. Instead, buy the dip on these four fabulous dividend winners.

Newly public Omada Health says it won't turn patient care over to AI as the tech consumes investor interest.

Even the Hamburglar didn’t see this one coming.Excessive weight has been a persistent problem in America, where at least one ...

Coca-Cola remains resilient amid GLP-1 health trends and geopolitical risks, with proactive innovation and a diversified ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

Amazon AMZN.O chief executive Andy Jassy on Thursday justified the company's billions of dollars in outlays for artificial intelligence development, saying the investment was necessary to remain ...